< Back to Research Centers

About This Center

The RCOE at the Mayo Clinic campus in Rochester, Minnesota was the Coordinating Center for the whole LBDA Research Centers of Excellence program from 2017 to 2024, and is proud to continue as a very active site in the RCOE program. The RCOE program is in the Department of Neurology which includes over 90 neurologists with permanent appointments to the medical staff. There are 12 neurology divisions, many (including the Behavioral Neurology Division) integrating subspecialty interests. The Department has several clinical and research laboratories. The Mayo Clinic Department of Neurology has a large clinical practice and numerous research programs. This rich patient resource permits a broad and comprehensive range of clinical, educational, and research activities throughout the Department.

The Outreach and Engagement staff at the Center provides support, information and guidance to those living with LBD and their families through in-person or virtual meetings, as well as workshops, programs, and events that focus on understanding the unique aspects of LBD, uncovering personal strengths, and promoting overall well-being. In addition, the Outreach and Engagement staff can connect people living with dementia and their care partners to LBD specific support groups, as well as dementia-friendly activities in the community at large, such as Memory cafes and arts based opportunities.

Location

Contact Information

Clinical trials: By invitation only

Clinic name: Mayo Clinic Alzheimer’s Disease Research Center
Name: Nick Rethemeier
Email: [email protected]
Phone: 507-538-4048
Contact for: General inquiries, support groups and other LBD related resources
Website: Alzheimer’s Disease Research Center

Clinic name: Mayo Clinic Department of Neurology
Name: Neurology Appointment Office
Phone: 507-538-1038
Contact for: Clinic Appointments
Website: Mayo Clinic Department of Neurology

Bradley Boeve, MD

Dr. Boeve is a board-certified neurologist with subspecialty training in behavioral neurology and sleep medicine, and he serves as the Lead Principal Investigator of the RCOE Program at Mayo Clinic Rochester. He is the endowed Little Family Foundation Professor in Lewy Body Dementia. Over the past 25 years, he has been particularly interested in the clinical, sleep, neuropsychological, genetic, neuroimaging, and neuropathologic aspects of the neurodegenerative disorders which manifest as cognitive impairment and/or parkinsonism – namely mild cognitive impairment, Alzheimer’s disease, dementia with Lewy bodies, Parkinson’s disease, frontotemporal dementia +/- parkinsonism, corticobasal syndrome/corticobasal degeneration, and progressive supranuclear palsy. He is a member of the Scientific Advisory Council of the Lewy Body Dementia Association. He was the PI of the Coordinating Center for the LBDA RCOE over 2017-2024. He is Co-PI of the North American Prodromal Synucleinopathy (NAPS) Consortium, Co-PI of the Longitudinal Imaging Biomarkers of Disease Progression in DLB Protocol, Co-PI of the Lewy Body Disease Functional Genomics Program, Director of the Mayo Clinic Alzheimer’s Disease Research Center, among other administrative and research responsibilities. He is funded by the National Institute on Aging, National Institute of Neurological Disorders and Stroke, American Brain Foundation, Michael J. Fox Foundation, the Little Family Foundation, the Mangurian Foundation, Ted Turner and Family, and Donald E. and Misty Fike.

Bradley Boeve, MD photo
Loading map...

Learn about LBD

Educational resources to assist individuals with LBD, their families and healthcare providers.

Program thumbnail

Lewy Trial Tracker

You can accelerate research by participating in clinical studies. Sign up for the Lewy Trial Tracker today.

Program thumbnail

Research Centers

Through its Research Centers of Excellence, LBDA partners with 27 leading institutions to provide advanced care and connect the LBD community with specialized, research‑driven expertise.

Program thumbnail

Advisory Council

The LBDA Advisory Council (AC) convenes leaders in the LBD academic medical/scientific community, federal agencies and biotech companies with the aim of advancing the study of LBD diagnostic tools and treatments.